109 related articles for article (PubMed ID: 27274011)
21. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
Charpignon C; Beau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
[TBL] [Abstract][Full Text] [Related]
22. Assessment of intracellular methotrexate and methotrexate-polyglutamate metabolite concentrations in erythrocytes by ultrafast matrix-assisted laser desorption/ionization triple quadrupole tandem mass spectrometry.
Meesters RJ; den Boer E; de Jonge R; Lindemans J; Luider TM
Rapid Commun Mass Spectrom; 2011 Oct; 25(20):3063-70. PubMed ID: 21953961
[TBL] [Abstract][Full Text] [Related]
23. Red blood cell methotrexate polyglutamates emerge as a function of dosage intensity and route of administration during pulse methotrexate therapy in rheumatoid arthritis.
Dervieux T; Zablocki R; Kremer J
Rheumatology (Oxford); 2010 Dec; 49(12):2337-45. PubMed ID: 20713496
[TBL] [Abstract][Full Text] [Related]
24. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.
Feagan BG; Rochon J; Fedorak RN; Irvine EJ; Wild G; Sutherland L; Steinhart AH; Greenberg GR; Gillies R; Hopkins M
N Engl J Med; 1995 Feb; 332(5):292-7. PubMed ID: 7816064
[TBL] [Abstract][Full Text] [Related]
25. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
Nathan DM; Iser JH; Gibson PR
J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study.
Dervieux T; Furst D; Lein DO; Capps R; Smith K; Caldwell J; Kremer J
Ann Rheum Dis; 2005 Aug; 64(8):1180-5. PubMed ID: 15677700
[TBL] [Abstract][Full Text] [Related]
27. Folate and methotrexate polyglutamate tissue levels in rhesus monkeys following chronic low-dose methotrexate.
Winick NJ; Kamen BA; Balis FM; Holcenberg J; Lester CM; Poplack DG
Cancer Drug Deliv; 1987; 4(1):25-31. PubMed ID: 2440550
[TBL] [Abstract][Full Text] [Related]
28. Methotrexate polyglutamate concentrations and association with disease control in rheumatoid arthritis: comment on the article by Stamp et al.
Dervieux T; Kremer J
Arthritis Rheum; 2010 Aug; 62(8):2559-60; author reply 2560-1. PubMed ID: 20506252
[No Abstract] [Full Text] [Related]
29. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
Feagan BG; Fedorak RN; Irvine EJ; Wild G; Sutherland L; Steinhart AH; Greenberg GR; Koval J; Wong CJ; Hopkins M; Hanauer SB; McDonald JW
N Engl J Med; 2000 Jun; 342(22):1627-32. PubMed ID: 10833208
[TBL] [Abstract][Full Text] [Related]
30. Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial.
Oren R; Moshkowitz M; Odes S; Becker S; Keter D; Pomeranz I; Shirin H; Reisfeld I; Broide E; Lavy A; Fich A; Eliakim R; Patz J; Villa Y; Arber N; Gilat T
Am J Gastroenterol; 1997 Dec; 92(12):2203-9. PubMed ID: 9399753
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate in Crohn's disease: long-term efficacy and toxicity.
Lémann M; Zenjari T; Bouhnik Y; Cosnes J; Mesnard B; Rambaud JC; Modigliani R; Cortot A; Colombel JF
Am J Gastroenterol; 2000 Jul; 95(7):1730-4. PubMed ID: 10925976
[TBL] [Abstract][Full Text] [Related]
32. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
[TBL] [Abstract][Full Text] [Related]
33. A novel high-performance liquid chromatography/mass spectrometry method for improved selective and sensitive measurement of methotrexate polyglutamation status in human red blood cells.
van Haandel L; Becker ML; Leeder JS; Williams TD; Stobaugh JF
Rapid Commun Mass Spectrom; 2009 Dec; 23(23):3693-702. PubMed ID: 19902549
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
Weiss B; Lerner A; Shapiro R; Broide E; Levine A; Fradkin A; Bujanover Y
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
[TBL] [Abstract][Full Text] [Related]
35. Bioavailability of oral vs. subcutaneous low-dose methotrexate in patients with Crohn's disease.
Kurnik D; Loebstein R; Fishbein E; Almog S; Halkin H; Bar-Meir S; Chowers Y
Aliment Pharmacol Ther; 2003 Jul; 18(1):57-63. PubMed ID: 12848626
[TBL] [Abstract][Full Text] [Related]
36. An improved high-performance liquid chromatography method for quantification of methotrexate polyglutamates in red blood cells of children with juvenile idiopathic arthritis.
Hroch M; Tuková J; Dolezalová P; Chládek J
Biopharm Drug Dispos; 2009 Apr; 30(3):138-48. PubMed ID: 19322908
[TBL] [Abstract][Full Text] [Related]
37. Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity.
Vermeire S; Schreiber S; Sandborn WJ; Dubois C; Rutgeerts P
Clin Gastroenterol Hepatol; 2010 Apr; 8(4):357-63. PubMed ID: 20096379
[TBL] [Abstract][Full Text] [Related]
38. Studies on the intracellular accumulation process of methotrexate and its correlation with the key protein using an LC-MS/MS method: a novel way to realize prospective individualized medication.
Ouyang Z; Huang J; Ren Y; Li H; Ding Y; Zhang K; Jiang L; Yu P
Anal Bioanal Chem; 2021 Mar; 413(7):1799-1807. PubMed ID: 33564926
[TBL] [Abstract][Full Text] [Related]
39. Simplification of a pharmacokinetic model for red blood cell methotrexate disposition.
Pan S; Korell J; Stamp LK; Duffull SB
Eur J Clin Pharmacol; 2015 Dec; 71(12):1509-16. PubMed ID: 26407686
[TBL] [Abstract][Full Text] [Related]
40. Determination of erythrocyte methotrexate polyglutamates by liquid chromatography/tandem mass spectrometry after low-dose methotrexate therapy in Chinese patients with rheumatoid arthritis.
Mo X; Wen Y; Ren B; Chen J; Xu C; Wang X; Huang M; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():41-8. PubMed ID: 22999476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
